Join
Live feed
·
PRReleasevia Quantisnow
YS Biopharma Co. Ltd. logo

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

ByQuantisnow·Wall Street's wire, on your screen.
YS· YS Biopharma Co. Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YS (YS Biopharma Co. Ltd.) and more on Quantisnow.